Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vincerx Pharma Inc VINC

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:VINC)

No current opinion is available.

Bullboard Posts (NDAQ:VINC)

Vincerx Pharma, Inc. (VINC): A Promising Oncology Biotech Na

http://beyondspx.com/2024/08/02/vincerx-pharma-inc-vinc-a-promising-oncology-biotech-navigating-the-challenges-of-early-stage-development...
MikeTester - August 3, 2024

Vincerx Pharma Announces Pricing of Underwritten Public Offe

BREAKING NEWS: $VINC Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants | BenzingaPALO ALTO...
whytestocks - April 26, 2024

Vincerx Pharma Announces Pricing of Underwritten Public Offe

NEWS: $VINC Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsPALO ALTO, Calif., April 25...
whytestocks - April 26, 2024

CDK9 inhibitor

enitociclib and CDK9 are not unknowns, but it is great to see it being used in logical combos. Seeing some synergy that would be unlikely...
aee - February 22, 2024